Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Advanced Knee Osteoarthritis with Effusion-synovitis
NCT03815448Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Jul 2019
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in knee osteoarthritis (OA) comparing Methotrexate with Placebo (2 arms). Primary endpoints: Effusion-synovitis volume measured by MRI at 12 months and Visual Analogue Scale Knee Pain at 12 months. Started Jul 2019; status: completed.
02
Drugs
methotrexate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03815448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815448.